106 related articles for article (PubMed ID: 37580943)
1. Identifying potential anti-metastasis drugs for prostate cancer through integrative bioinformatics analysis and compound library screening.
Li ZW; Yu JF; Han F; Peng J; Lu Y; Ding K
J Gene Med; 2023 Nov; 25(11):e3548. PubMed ID: 37580943
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
[TBL] [Abstract][Full Text] [Related]
3. [Identification and validation of hub genes in prostate cancer progression based on weighted gene co-expression network analysis].
Zhang H; Chen N; Wang X; Gao B; Ling M; Chen G; Wu Z; Li Y; Zhong W; Pan B
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1631-1640. PubMed ID: 34916188
[TBL] [Abstract][Full Text] [Related]
4. Identification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression.
Zhang J; Ding X; Peng K; Jia Z; Yang J
Aging (Albany NY); 2022 Jun; 14(11):4839-4857. PubMed ID: 35680563
[TBL] [Abstract][Full Text] [Related]
5. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach.
Huang H; Zhang Q; Ye C; Lv JM; Liu X; Chen L; Wu H; Yin L; Cui XG; Xu DF; Liu WH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2571-2579. PubMed ID: 28849390
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
8. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression.
Li Y; Vongsangnak W; Chen L; Shen B
BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S3. PubMed ID: 25080090
[TBL] [Abstract][Full Text] [Related]
10. Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients.
Che H; Liu Y; Zhang M; Meng J; Feng X; Zhou J; Liang C
Med Sci Monit; 2019 Dec; 25():9991-10007. PubMed ID: 31876269
[TBL] [Abstract][Full Text] [Related]
11. Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis.
Cheng Y; Li L; Qin Z; Li X; Qi F
J Cell Mol Med; 2020 Jul; 24(14):8006-8017. PubMed ID: 32485038
[TBL] [Abstract][Full Text] [Related]
12. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.
Yeh HY; Cheng SW; Lin YC; Yeh CY; Lin SF; Soo VW
BMC Med Genomics; 2009 Dec; 2():70. PubMed ID: 20025723
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
Qiao G; Xing J; Luo X; Zhang C; Yi J
Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
[TBL] [Abstract][Full Text] [Related]
14. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
[TBL] [Abstract][Full Text] [Related]
15. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
16. LncRNA weighted gene co-expression network analysis reveals novel biomarkers related to prostate cancer metastasis.
Liu M; Chen MY; Huang JM; Liu Q; Wang L; Liu R; Yang N; Huang WH; Zhang W
BMC Med Genomics; 2022 Dec; 15(1):256. PubMed ID: 36514044
[TBL] [Abstract][Full Text] [Related]
17. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
[TBL] [Abstract][Full Text] [Related]
19. Identifying hub genes of calcific aortic valve disease and revealing the immune infiltration landscape based on multiple WGCNA and single-cell sequence analysis.
Wang K; Zheng Q; Liu X; Geng B; Dong N; Shi J
Front Immunol; 2022; 13():1035285. PubMed ID: 36405745
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]